$FTHM
Fathom Holdings Inc Stock $fthm

$fthm Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000162828024011953 Filed on March 19, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$70.50M	$74.07M	$345.2M
YoY Change	-9.08%	-11.22%	-16.4%
Cost Of Revenue	$63.28M	$68.37M	$315.6M
YoY Change	-10.61%	-13.53%	-17.05%
Gross Profit	$7.227M	$5.701M	$29.62M
YoY Change	6.99%	30.43%	-8.78%
Gross Profit Margin	10.25%	7.7%	8.58%
Selling, General & Admin	$10.20M	$11.00M	$42.10M
YoY Change	-1.11%	12.06%	-13.08%
% of Gross Profit	141.17%	192.95%	142.14%
Research & Development	$1.950M	$2.040M	$7.609M
YoY Change	51.16%	-46.09%	-1.37%
% of Gross Profit	26.98%	35.78%	25.69%
Depreciation & Amortization	$1.480M	$1.481M	$5.947M
YoY Change	9.06%	-5.12%	11.24%
% of Gross Profit	20.48%	25.98%	20.08%
Operating Expenses	$76.16M	$13.80M	$52.87M
YoY Change	-8.34%	-4.57%	-10.76%
Operating Profit	-$5.653M	-$8.097M	-$23.25M
YoY Change	1.93%	-19.74%	-13.16%
Interest Expense	-$105.0K	-$94.00K	-$245.0K
YoY Change	-756.25%	-726.67%	-2327.27%
% of Operating Profit
Other Income/Expense, Net	-$257.0K	-$154.0K	-$335.0K
YoY Change	79.72%	35.09%	-63.35%
Pretax Income	-$5.910M	-$8.345M	-$23.83M
YoY Change	3.88%	-18.08%	-13.9%
Income Tax	$17.00K	$94.00K	$148.0K
% Of Pretax Income
Net Earnings	-$5.927M	-$8.439M	-$23.98M
YoY Change	3.96%	-15.17%	-13.19%
Net Earnings / Revenue	-8.41%	-11.39%	-6.95%
Basic Earnings Per Share	-$0.31		-$1.47
Diluted Earnings Per Share	-$0.31	-$0.50	-$1.47
COMMON SHARES
Basic Shares Outstanding	20.78M shares	18.17M shares	16.27M shares
Diluted Shares Outstanding	19.18M shares		16.27M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.682M	$7.399M	$7.399M
YoY Change	-15.48%	-11.07%	-11.07%
Cash & Equivalents	$5.700M	$7.399M	$7.399M
Short-Term Investments
Other Short-Term Assets	$13.61M	$12.44M	$12.44M
YoY Change	66.75%	67.65%	67.65%
Inventory
Prepaid Expenses
Receivables	$2.996M	$3.352M	$3.352M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$22.29M	$23.19M	$23.19M
YoY Change	21.83%	23.27%	23.27%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.224M	$6.490M	$6.490M
YoY Change	-21.36%	-23.22%	-23.22%
Goodwill	$25.61M	$25.61M
YoY Change	0.0%	0.0%
Intangibles	$23.08M	$23.91M
YoY Change	-13.26%	-12.29%
Long-Term Investments
YoY Change
Other Assets	$50.00K	$58.00K	$58.00K
YoY Change	-9.09%	11.54%	11.54%
Total Long-Term Assets	$55.96M	$56.06M	$56.06M
YoY Change	-7.16%	-8.65%	-8.65%
TOTAL ASSETS
Total Short-Term Assets	$22.29M	$23.19M	$23.19M
Total Long-Term Assets	$55.96M	$56.06M	$56.06M
Total Assets	$78.25M	$79.26M	$79.26M
YoY Change	-0.41%	-1.16%	-1.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.830M	$3.396M	$3.396M
YoY Change	-3.94%	1.59%	1.59%
Accrued Expenses	$3.710M	$4.185M	$4.185M
YoY Change	-2.73%	-16.5%	-16.5%
Deferred Revenue
YoY Change
Short-Term Debt	$5.584M	$8.355M	$8.355M
YoY Change	24.73%	133.38%	133.38%
Long-Term Debt Due	$246.0K	$416.0K	$416.0K
YoY Change	-84.96%	-26.24%	-26.24%
Total Short-Term Liabilities	$17.81M	$16.35M	$16.35M
YoY Change	25.58%	30.83%	30.83%
LONG-TERM LIABILITIES
Long-Term Debt	$3.490M	$3.467M	$3.467M
YoY Change	3192.45%	2587.6%	2587.6%
Other Long-Term Liabilities	$386.0K	$4.205M	$4.205M
YoY Change	29.97%	-24.07%	-24.07%
Total Long-Term Liabilities	$3.876M	$7.672M	$7.672M
YoY Change	1205.05%	35.38%	35.38%
TOTAL LIABILITIES
Total Short-Term Liabilities	$17.81M	$16.35M	$16.35M
Total Long-Term Liabilities	$3.876M	$7.672M	$7.672M
Total Liabilities	$26.32M	$24.02M	$24.02M
YoY Change	35.45%	32.25%	32.25%
SHAREHOLDERS EQUITY
Retained Earnings	-$77.51M	-$71.59M
YoY Change	45.41%	50.37%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$51.93M	$55.23M	$55.23M
YoY Change
Total Liabilities & Shareholders Equity	$78.25M	$79.26M	$79.26M
YoY Change	-0.41%	-1.16%	-1.16%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$5.927M	-$8.439M	-$23.98M
YoY Change	3.96%	-15.17%	-13.19%
Depreciation, Depletion And Amortization	$1.480M	$1.481M	$5.947M
YoY Change	9.06%	-5.12%	11.24%
Cash From Operating Activities	-$947.0K	-$4.366M	-$10.57M
YoY Change	-39.68%	3763.72%	60.6%
INVESTING ACTIVITIES
Capital Expenditures	$1.000K	$475.0K	$1.833M
YoY Change	-88.89%	-21.23%	-54.82%
Acquisitions			$35.00K
YoY Change			-97.86%
Other Investing Activities		-$35.00K	-$35.00K
YoY Change		-93.75%	-98.85%
Cash From Investing Activities	-$535.0K	-$510.0K	-$1.868M
YoY Change	-9.01%	-56.15%	-73.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$4.900M
YoY Change			-181.06%
Debt Paid & Issued, Net	$148.0K		$718.0K
YoY Change	-53.46%		-45.07%
Cash From Financing Activities	-$96.00K	5.654M	11.60M
YoY Change	-116.58%	-212.5%	-173.13%
NET CHANGE
Cash From Operating Activities	-$947.0K	-4.366M	-10.57M
Cash From Investing Activities	-$535.0K	-510.0K	-1.868M
Cash From Financing Activities	-$96.00K	5.654M	11.60M
Net Change In Cash	-$1.578M	778.0K	-840.0K
YoY Change	-0.06%	-112.35%	-97.16%
FREE CASH FLOW
Cash From Operating Activities	-$947.0K	-$4.366M	-$10.57M
Capital Expenditures	$1.000K	$475.0K	$1.833M
Free Cash Flow	-$948.0K	-$4.841M	-$12.41M
YoY Change	-39.96%	576.12%	16.59%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	fthm	Operations And Support Expense OperationsAndSupportExpense	7513000	usd
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.47
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.73
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001753162
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-39412
CY2023	dei	Entity Registrant Name EntityRegistrantName	FATHOM HOLDINGS INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NC
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-1518164
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	2000 Regency Parkway Drive
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 300
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Cary
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NC
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	27518
CY2023	dei	City Area Code CityAreaCode	888
CY2023	dei	Local Phone Number LocalPhoneNumber	455-6040
CY2023	dei	Security12b Title Security12bTitle	Common Stock, No Par Value
CY2023	dei	Trading Symbol TradingSymbol	FTHM
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	66327887	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20776292	shares
CY2023	dei	Auditor Firm AuditorFirmId	34
CY2023	dei	Auditor Name AuditorName	Deloitte & Touche LLP
CY2023	dei	Auditor Location AuditorLocation	Raleigh, North Carolina
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7399000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8320000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	141000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	60000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3352000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3074000	usd
CY2023Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	8602000	usd
CY2022Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	3694000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3700000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3668000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	23194000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	18816000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2340000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2945000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4150000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5508000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	23909000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	27259000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	25607000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	25607000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	58000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	52000	usd
CY2023Q4	us-gaap	Assets Assets	79258000	usd
CY2022Q4	us-gaap	Assets Assets	80187000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3396000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3343000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2681000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3403000	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	8355000	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	3580000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1504000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1609000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	416000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	564000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	16352000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12499000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3824000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5241000	usd
CY2023Q4	fthm	Long Term Debt Excluding Current Maturities And Notes Payable LongTermDebtExcludingCurrentMaturitiesAndNotesPayable	3467000	usd
CY2022Q4	fthm	Long Term Debt Excluding Current Maturities And Notes Payable LongTermDebtExcludingCurrentMaturitiesAndNotesPayable	129000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	381000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	297000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	24024000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	18166000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20671515	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20671515	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17468562	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17468562	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	126820000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	109626000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-71586000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-47605000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	55234000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	62021000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	79258000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	80187000	usd
CY2023	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	308094000	usd
CY2022	fthm	Operations And Support Expense OperationsAndSupportExpense	8249000	usd
CY2023	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	7609000	usd
CY2022	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	7715000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	38751000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	43217000	usd
CY2023	us-gaap	Marketing Expense MarketingExpense	3348000	usd
CY2022	us-gaap	Marketing Expense MarketingExpense	5218000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3164000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3096000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	368479000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	439741000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-23253000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-26777000	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-245000	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	11000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-335000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-914000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-580000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-903000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-23833000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-27680000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	148000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-54000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-23981000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-27626000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.47
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.73
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.47
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.73
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16265993	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16001367	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16265993	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16001367	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	62021000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4900000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	745000	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	12994000	usd
CY2023	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	45000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	80150000	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	6191000	usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	6045000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	9351000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-27626000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	62021000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-23981000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-27626000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5947000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5346000	usd
CY2023	fthm	Non Cash Lease Expense NonCashLeaseExpense	1663000	usd
CY2022	fthm	Non Cash Lease Expense NonCashLeaseExpense	1856000	usd
CY2023	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	71000	usd
CY2022	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	0	usd
CY2023	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	3696000	usd
CY2022	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	3819000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	12994000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	9131000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	84000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	297000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	278000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-485000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	232000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	958000	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-195000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-78000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	53000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1959000	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-353000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1081000	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1827000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1867000	usd
CY2023	us-gaap	Increase Decrease In Mortgage Loans Held For Sale IncreaseDecreaseInMortgageLoansHeldForSale	154480000	usd
CY2022	us-gaap	Increase Decrease In Mortgage Loans Held For Sale IncreaseDecreaseInMortgageLoansHeldForSale	246327000	usd
CY2023	fthm	Proceeds From Sale And Principal Of Mortgage Loan Held For Sale ProceedsFromSaleAndPrincipalOfMortgageLoanHeldForSale	153268000	usd
CY2022	fthm	Proceeds From Sale And Principal Of Mortgage Loan Held For Sale ProceedsFromSaleAndPrincipalOfMortgageLoanHeldForSale	259861000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10572000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6583000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	22000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	945000	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	35000	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1639000	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1811000	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	3112000	usd
CY2023	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	usd
CY2022	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	1400000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1868000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7096000	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	718000	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1307000	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	4036000	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	924000	usd
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	200000	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2023	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-449000	usd
CY2022	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	usd
CY2023	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	150265000	usd
CY2022	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	210433000	usd
CY2023	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	145489000	usd
CY2022	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	219867000	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	6045000	usd
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	4900000	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	745000	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	11600000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-15862000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-840000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-29541000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8380000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37921000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7540000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8380000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	188000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	4000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	50000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	111000	usd
CY2023	fthm	Amount Due To Seller AmountDueToSeller	80000	usd
CY2022	fthm	Amount Due To Seller AmountDueToSeller	1100000	usd
CY2023	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	305000	usd
CY2022	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	2385000	usd
CY2023	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	45000	usd
CY2022	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	6168000	usd
CY2023	fthm	Capitalized Share Based Compensation Expense CapitalizedShareBasedCompensationExpense	0	usd
CY2022	fthm	Capitalized Share Based Compensation Expense CapitalizedShareBasedCompensationExpense	220000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7399000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8320000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	141000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	60000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7540000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8380000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Certain Significant Risks and Business Uncertainties</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> — The Company is subject to the risks and challenges associated with companies at a similar stage of development. These include dependence on key individuals, successful development and marketing of its offerings, and competition with larger companies with greater financial, technical, and marketing resources. Furthermore, during the period required to achieve substantially higher revenue in order to become consistently profitable, the Company may require additional funds that might not be readily available or might not be on terms that are acceptable to the Company.</span></div>
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-24000000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-27600000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7400000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8300000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> — The preparation of consolidated financial statements, in conformity with GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates its estimates and assumptions related to provisions for doubtful accounts, legal contingencies, income taxes, deferred tax asset valuation allowances, share-based compensation, goodwill, estimated lives of intangible assets, and intangible asset impairment. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company might differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</span></div>
CY2023Q4	fthm	Agent Annual Fees Receivable Net AgentAnnualFeesReceivableNet	2400000	usd
CY2022Q4	fthm	Agent Annual Fees Receivable Net AgentAnnualFeesReceivableNet	2300000	usd
CY2023	fthm	Agent Fees AgentFees	600000	usd
CY2022	fthm	Agent Fees AgentFees	500	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022	fthm	Business Combinations Number Of Acquisitions BusinessCombinationsNumberOfAcquisitions	2	acquisition
CY2022Q4	us-gaap	Goodwill Goodwill	25607000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	25607000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3776000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3754000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1436000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	809000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2340000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2945000	usd
CY2022	us-gaap	Depreciation Depreciation	600000	usd
CY2023	us-gaap	Depreciation Depreciation	600000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	36741000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	12832000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	23909000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	34771000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7512000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	27259000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	5447000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	5194000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	4558000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	3559000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	2419000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	2732000	usd
CY2023Q4	fthm	Finite Lived Intangible Assets Amortization Expense Due FiniteLivedIntangibleAssetsAmortizationExpenseDue	23909000	usd
CY2023Q4	fthm	Deferred Annual Fees Current DeferredAnnualFeesCurrent	948000	usd
CY2022Q4	fthm	Deferred Annual Fees Current DeferredAnnualFeesCurrent	1100000	usd
CY2023Q4	fthm	Due To Sellers DueToSellers	488000	usd
CY2022Q4	fthm	Due To Sellers DueToSellers	857000	usd
CY2023Q4	fthm	Accrued Compensation And Other Employer Cost AccruedCompensationAndOtherEmployerCost	526000	usd
CY2022Q4	fthm	Accrued Compensation And Other Employer Cost AccruedCompensationAndOtherEmployerCost	884000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	719000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	562000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2681000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3403000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	394000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	3372000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	117000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	3883000	usd
CY2023Q4	fthm	Derivative Asset Current Statement Of Financial Position Extensible Enumeration Not Disclosed Flag DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag	true
CY2023Q4	fthm	Derivative Liability Statement Of Financial Position Extensible Enumeration Not Disclosed Flag DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag	true
CY2022Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	10000000	usd
CY2022	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	686097	shares
CY2022	fthm	Stock Repurchase Program Authorized Amount One StockRepurchaseProgramAuthorizedAmountOne	6000000	usd
CY2023	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	0	shares
CY2023Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	4000000	usd
CY2020Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	240100	shares
CY2020Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.00
CY2023Q4	fthm	Number Of Underwriters Warrants Exercised Or Expired NumberOfUnderwritersWarrantsExercisedOrExpired	0	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	43996	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	20.46
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y6M
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	510000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	103711	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	8.22
CY2022	fthm	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm	P9Y8M1D
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	147707	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.87
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y3M25D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	147707	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.87
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y3M25D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	147707	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	11.87
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P9Y3M25D
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	8.22
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12994000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9131000	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	0	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	200000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	1663000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	1856000	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	701000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	550000	usd
CY2023	us-gaap	Lease Cost LeaseCost	2364000	usd
CY2022	us-gaap	Lease Cost LeaseCost	2406000	usd
CY2023Q4	fthm	Operating Leases Right Of Use Asset OperatingLeasesRightOfUseAsset	4150000	usd
CY2022Q4	fthm	Operating Leases Right Of Use Asset OperatingLeasesRightOfUseAsset	7363000	usd
CY2023Q4	fthm	Operating Leases Right Of Use Asset OperatingLeasesRightOfUseAsset	4150000	usd
CY2022Q4	fthm	Operating Leases Right Of Use Asset OperatingLeasesRightOfUseAsset	7363000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1504000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1609000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3824000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5241000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	5328000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	6850000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y10M24D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y8M12D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0633
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0619
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1785000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1479000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1066000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	969000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	22000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	135000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	40000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-50000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-116000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	709000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	6008000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	680000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	5328000	usd
CY2023	us-gaap	Payments For Rent PaymentsForRent	400000	usd
CY2022	us-gaap	Payments For Rent PaymentsForRent	500000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-23981000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-23981000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-27626000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-27626000	usd
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16265993	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16265993	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16001367	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16001367	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.47
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.73
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	392564	shares
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	63000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	22000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	63000	usd
CY2023	fthm	Deferred Income Tax Expense Benefit Total DeferredIncomeTaxExpenseBenefitTotal	85000	usd
CY2022	fthm	Deferred Income Tax Expense Benefit Total DeferredIncomeTaxExpenseBenefitTotal	-76000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	148000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-54000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-5006000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-5822000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-388000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.02
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-505000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.02
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4785000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.20
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	6274000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.23
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	10000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	6000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0
CY2023	fthm	Effective Income Tax Rate Reconciliation Return To Provision Adjustments Amount EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentsAmount	737000	usd
CY2023	fthm	Effective Income Tax Rate Reconciliation Return To Provision Adjustments Percentage EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentsPercentage	-0.03
CY2022	fthm	Effective Income Tax Rate Reconciliation Return To Provision Adjustments Amount EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentsAmount	0	usd
CY2022	fthm	Effective Income Tax Rate Reconciliation Return To Provision Adjustments Percentage EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentsPercentage	0
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	10000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-7000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	148000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-54000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.006
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.002
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	345226000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	412964000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	11376000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	9383000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	112000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	134000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	94000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3963000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2270000	usd
CY2023Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	60000	usd
CY2022Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	18000	usd
CY2023Q4	fthm	Deferred Tax Assets Tax Credit Carry Forwards Research And Development DeferredTaxAssetsTaxCreditCarryForwardsResearchAndDevelopment	35000	usd
CY2022Q4	fthm	Deferred Tax Assets Tax Credit Carry Forwards Research And Development DeferredTaxAssetsTaxCreditCarryForwardsResearchAndDevelopment	35000	usd
CY2023Q4	fthm	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	1228000	usd
CY2022Q4	fthm	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	1566000	usd
CY2023Q4	fthm	Deferred Tax Asset Basis In Partnership DeferredTaxAssetBasisInPartnership	2000	usd
CY2022Q4	fthm	Deferred Tax Asset Basis In Partnership DeferredTaxAssetBasisInPartnership	2000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	36000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	28000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	16946000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	13396000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	0	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	54000	usd
CY2023Q4	fthm	Deferred Tax Liabilities Intangibles DeferredTaxLiabilitiesIntangibles	2693000	usd
CY2022Q4	fthm	Deferred Tax Liabilities Intangibles DeferredTaxLiabilitiesIntangibles	3247000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Software DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware	499000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Software DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware	692000	usd
CY2023Q4	fthm	Deferred Tax Liabilities Unrealized Gain Or Loss DeferredTaxLiabilitiesUnrealizedGainOrLoss	0	usd
CY2022Q4	fthm	Deferred Tax Liabilities Unrealized Gain Or Loss DeferredTaxLiabilitiesUnrealizedGainOrLoss	29000	usd
CY2023Q4	fthm	Deferred Tax Liabilities Right Of Use Assets DeferredTaxLiabilitiesRightOfUseAssets	956000	usd
CY2022Q4	fthm	Deferred Tax Liabilities Right Of Use Assets DeferredTaxLiabilitiesRightOfUseAssets	1259000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	269000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	287000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	4417000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	5568000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	12911000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	8125000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	382000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	297000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023	fthm	Adjusted Earnings Before Interest Taxes Depreciation And Amortization AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization	-4111000	usd
CY2022	fthm	Adjusted Earnings Before Interest Taxes Depreciation And Amortization AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization	-12227000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5947000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5346000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-580000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-903000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	148000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-54000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	12994000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	9131000	usd
CY2023	fthm	Other Non Cash Transaction Related Costs OtherNonCashTransactionRelatedCosts	201000	usd
CY2022	fthm	Other Non Cash Transaction Related Costs OtherNonCashTransactionRelatedCosts	73000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-23981000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-27626000	usd
CY2023Q4	fthm	Cash Balance Commitment Amount CashBalanceCommitmentAmount	1400000	usd
CY2022Q4	fthm	Cash Balance Commitment Amount CashBalanceCommitmentAmount	1800000	usd
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false

Files In Submission

Name	View Source	Status
0001628280-24-011953-index-headers.html	Edgar Link	pending
0001628280-24-011953-index.html	Edgar Link	pending
0001628280-24-011953.txt	Edgar Link	pending
0001628280-24-011953-xbrl.zip	Edgar Link	pending
a10ksubsidiaries.htm	Edgar Link	pending
fathomholdingsinc-incentiv.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fthm-20231231.htm	Edgar Link	pending
fthm-20231231.xsd	Edgar Link	pending
fthm-20231231xex311.htm	Edgar Link	pending
fthm-20231231xex321.htm	Edgar Link	pending
fthm-20231231_g1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
fthm-20231231_def.xml	Edgar Link	unprocessable
fthm-20231231_cal.xml	Edgar Link	unprocessable
fthm-20231231_lab.xml	Edgar Link	unprocessable
fthm-20231231_pre.xml	Edgar Link	unprocessable
fthm-20231231_htm.xml	Edgar Link	completed
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
rep-00610kconsent1.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FTHM
Fathom Holdings Inc Stock $fthm

2024 Q1 Form 10-K Financial Statement

#000162828024011953 Filed on March 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FTHM Fathom Holdings Inc Stock $fthm

2024 Q1 Form 10-K Financial Statement

#000162828024011953 Filed on March 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FTHM
Fathom Holdings Inc Stock $fthm